DAILYZ HEALTH NEWS

Eli Lilly weight loss drug may treat fatty liver disease

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023.

Infectious Disease

February 18, 2024 Evan Vega

Risks for long symptoms after COVID during pregnancy tied to severity, comorbidities

February 13, 2024 2 min read Add topic to email alerts Receive an email when new articles are posted on

Infectious Disease

February 18, 2024 Evan Vega

What to know about long COVID in children

February 15, 2024 3 min read Add topic to email alerts Receive an email when new articles are posted on

Why we would be considering buying more Eli Lilly shares if they were down

Public Health

February 17, 2024 Evan Vega

Why we would be considering buying more Eli Lilly shares if they were down

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a

Public Health

February 17, 2024 Evan Vega

The Powerful Constraints on Medical Care in Catholic Hospitals Across America

Rachana Pradhan and Hannah Recht Nurse midwife Beverly Maldonado recalls a pregnant woman arriving at Ascension Saint Agnes Hospital in

Infectious Disease

February 17, 2024 Evan Vega

CDC identifies states with highest and lowest rates of long COVID

February 17, 2024 1 min read Add topic to email alerts Receive an email when new articles are posted on

Infectious Disease

February 17, 2024 Evan Vega

38.6% of children have received an HPV vaccine dose

February 16, 2024 1 min read Add topic to email alerts Receive an email when new articles are posted on

What to know about insurance coverage for weight loss drugs and costs

Public Health

February 17, 2024 Evan Vega

What to know about insurance coverage for weight loss drugs and costs

Many U.S. companies are grappling with health insurance coverage issues for workers when it comes to GLP-1 drugs for weight

Infectious Disease

February 17, 2024 Evan Vega

First Alaskapox death reported, officials say residents ‘shouldn’t be overly concerned’

February 16, 2024 3 min read Add topic to email alerts Receive an email when new articles are posted on

Infectious Disease

February 16, 2024 Evan Vega

COVID-19 increases insomnia risk in people with anxiety, depression

February 16, 2024 2 min read Add topic to email alerts Receive an email when new articles are posted on

DAILYZ HEALTH NEWS

DAILYZ HEALTH NEWS

WHO Issues Global Health Emergency Over Rapidly Spreading Drug-Resistant Tuberculosis Strain as Cases Detected in U.S. Travelers

Biden administration unveils new plan to cap insulin out-of-pocket costs at $35 for all insured Americans, expanding earlier Medicare-only protections

FDA Approves First Gene-Editing Therapy for Type 1 Diabetes, Marking Major Milestone in Cell-Based Treatment

Randomized trial in NEJM shows hybrid closed‑loop insulin pump improves A1c and reduces severe hypoglycemia in type 1 diabetes

FDA approves first oral small‑molecule treatment RebiQuent for moderate to severe atopic dermatitis in adults

WHO Issues Global Health Emergency Over Rapidly Spreading Drug-Resistant Tuberculosis Strain as Cases Detected in U.S. Travelers

Biden administration unveils new plan to cap insulin out-of-pocket costs at $35 for all insured Americans, expanding earlier Medicare-only protections

FDA Approves First Gene-Editing Therapy for Type 1 Diabetes, Marking Major Milestone in Cell-Based Treatment

Randomized trial in NEJM shows hybrid closed‑loop insulin pump improves A1c and reduces severe hypoglycemia in type 1 diabetes

WHO Issues Global Health Emergency Over Rapidly Spreading Drug-Resistant Tuberculosis Strain as Cases Detected in U.S. Travelers

Biden administration unveils new plan to cap insulin out-of-pocket costs at $35 for all insured Americans, expanding earlier Medicare-only protections

FDA Approves First Gene-Editing Therapy for Type 1 Diabetes, Marking Major Milestone in Cell-Based Treatment

Randomized trial in NEJM shows hybrid closed‑loop insulin pump improves A1c and reduces severe hypoglycemia in type 1 diabetes

FDA approves first oral small‑molecule treatment RebiQuent for moderate to severe atopic dermatitis in adults

WHO Issues Global Health Emergency Over Rapidly Spreading Drug-Resistant Tuberculosis Strain as Cases Detected in U.S. Travelers

Biden administration unveils new plan to cap insulin out-of-pocket costs at $35 for all insured Americans, expanding earlier Medicare-only protections

FDA Approves First Gene-Editing Therapy for Type 1 Diabetes, Marking Major Milestone in Cell-Based Treatment

Randomized trial in NEJM shows hybrid closed‑loop insulin pump improves A1c and reduces severe hypoglycemia in type 1 diabetes

WHO Issues Global Health Emergency Over Rapidly Spreading Drug-Resistant Tuberculosis Strain as Cases Detected in U.S. Travelers

Biden administration unveils new plan to cap insulin out-of-pocket costs at $35 for all insured Americans, expanding earlier Medicare-only protections

FDA Approves First Gene-Editing Therapy for Type 1 Diabetes, Marking Major Milestone in Cell-Based Treatment

Randomized trial in NEJM shows hybrid closed‑loop insulin pump improves A1c and reduces severe hypoglycemia in type 1 diabetes

FDA approves first oral small‑molecule treatment RebiQuent for moderate to severe atopic dermatitis in adults

Eli Lilly weight loss drug may treat fatty liver disease

Risks for long symptoms after COVID during pregnancy tied to severity, comorbidities

What to know about long COVID in children

Why we would be considering buying more Eli Lilly shares if they were down

The Powerful Constraints on Medical Care in Catholic Hospitals Across America

CDC identifies states with highest and lowest rates of long COVID

38.6% of children have received an HPV vaccine dose

What to know about insurance coverage for weight loss drugs and costs

First Alaskapox death reported, officials say residents ‘shouldn’t be overly concerned’

COVID-19 increases insomnia risk in people with anxiety, depression